AllDocs -> cancers

44 TABLE 21. ENDOMETRIAL ( UTERINE CORPUS) CANCER INCIDENCE BY COUNTY, WHITE FEMALES, NEW JERSEY - 1986-1996 1 COUNTY 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 (Prelim.) No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate Atlantic 24 19.9 26 22.6 23 17.4 15 14.2 27 22.9 33 24.5 30 24.2 37 31.2 35 27.9 26 21.4 22 18.0 Bergen 123 20.6 136 24.1 121 20.6 115 20.2 98 16.7 161 29.2 135 23.9 125 22.3 139 24.6 126 22.6 138 23.9 Burlington 26 13.7 41 22.1 31 15.9 40 19.2 42 21.3 38 19.3 35 18.0 59 28.9 57 26.8 57 28.2 47 22.3 Camden 50 18.8 43 15.1 50 19.3 61 22.2 61 23.0 61 23.8 55 21.9 45 18.3 55 22.0 ...

Copyright © 1998 by W.B. Saunders Company. All rights reserved. 510 A BASIC INFORMATION DESCRIPTION Cancer of the endometrium (lining of the uterus). It usually affects postmenopausal women ages 50 to 60. FREQUENT SIGNS AND SYMPTOMS Early stages: • Bleeding or spotting, especially after sexual inter- course. This often occurs after menstrual activity has ceased for 12 months or more. A watery or blood- streaked vaginal discharge may precede bleeding or spotting. • Enlarged uterus. It is sometimes a large enough mass to be felt externally. Later stages: • Spread to other organs, causing abdominal pain, chest pain and weight loss. CAUSES Unknown. Appears to be linked to several predisposing factors listed in Risk. RISK INCREASES WITH • Diabetes mellitus. • Obesity. • High blood pressure. • Use of estrogen without also ...

Page 2 Cancer of the uterus in England 1996 to 2004. A geographical profile of mortality. Authors: Michael Goldacre, David Yeates, Leicester Gill, Myfanwy Griffith, Henry McGuinness, Daniel Meddings Published by: Unit of Health-Care Epidemiology, Oxford University, and South East England Public Health Observatory, 2005 This document provides a geographical profile of mortality from cancer of the uterus in England. The geographical areas covered are the standard local authority areas of England. The period covered is January 1 1996 to December 31 2004. The data are analysed from mortality files supplied to the Public Health Observatories by the Office for National Statistics. This analysis includes mortality data about females of all ages. The map, chart and table show standardised mortality ratios (SMRs). The data in the map are shown as quintiles of local authorities, ...

UTERINE SARCOMA - CANCER SITES UTERINE SARCOMA What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells develop because of damage to DNA. This substance is in every cell and directs all its activities. Most of the time when DNA becomes damaged the body is able to repair it. ...

© Kamla-Raj 2003 KEYWORDS Cervix smears; micronuclei; exfoliated urine cells ABSTRACT Cytogenetic damage was assessed using the (MN) test in urothelial cells and cervix smears of local cervix cancer patients since the genetic end-point screening for micronuclei provides a measure of both, chromosome breakage and loss. The MN data were grouped for stage-types of cancer , age-groups, age-at- marriage, parity levels and socio-economic status. A comparison of the results obtained from both the tissues has revealed that the percent frequency of MNd cells was elevated in urothelial cells except when the variable for age-groups of the patients was compared. If validated, the MN assay in urothelial cells may prove useful for screening programmes for cervix cancer as besides scoring effectively for cytogenetic damage, it utilizes a non-invasive process of sample collection. INTRODUCTION ...

REVIEW ARTICLE CURRENT SCIENCE, VOL. 78, NO. 1, 10 JANUARY 2000 52 Cancer of the uterine cervix and human papillomavirus infection B. C. Das*, V. Gopalkrishna, Suresh Hedau and Sanjay Katiyar Division of Molecular Oncology, Institute of Cytology and Preventive Oncology (ICMR), Maulana Azad Medical College Campus, Bahadur Shah Zafar Marg, New Delhi 110 002, India Human papillomaviruses (HPVs) have emerged as the principal sexually transmitted causal agents in the development of cancer of the uterine cervix in women. They also cause a variety of benign lesions, warts, intraepithelial neoplasia and anogenital, oral and pharyngeal papillomas. Presently, more than 100 HPV genotypes have been identified in humans, and about one-third of them have been sequenced. Of these, while HPV types 16 and 18 are considered to be the high-risk types, HPV 6 and 11 ...

Survival prediction using artificial neural networks in patients with uterine cervical cancer Masahiro Iinuma, Kenya Murase Department of Medical Physics and Engineering, Graduate School of Medicine, Osaka University, Osaka, Japan Abstract Our purpose of this study was to construct the predict model using artificial neural networks (ANNs) from radiation oncology database. Although there is no guarantee that trained ANNs models reached an error minimum point, we made 40 models by each combination of hidden nodes (30, 50, 100, and 150). Using the trained ANNs, we predicted the survival in patients with uterine cervical cancer treated by radiation therapy. The performance of ANNs was evaluated using receiver operating characteristic (ROC) analysis by those maximums and the mean. Az value was the highest at the number of neuron 150, and the value was maximum ...

Age Sex Site Diagnosis pTNM Stage 1 70 F cervix squamous cell carcinoma T1aN0M0 I 2 46 F cervix squamous cell carcinoma T1a1N0M0 IA1 3 42 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 4 57 F cervix squamous cell carcinoma in situ TisN0M0 0 5 33 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 6 35 F cervix squamous cell carcinoma in situ TisN0M0 0 7 48 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 8 39 F cervix microinvasive squamous cell carcinoma T1N0M0 I 9 58 F cervix microinvasive squamous cell carcinoma T1N0M0 I 10 53 F cervix squamous cell carcinoma in situ TisN0M0 ...

Arq Neuropsiquiatr 2006;64(2-A):300-302 D e p a rtment of Neuro s u rg e ry, Hospital Nossa Senhora das Graças, Curitiba PR, Brazil: 1 Resident in Neuro s u rg e ry; 2 N e u ro s u rg e o n ; 3 Neurosurgeon, Federal University of Sergipe (Aracaju SE, Brasil); 4 Neurosurgeon Director of the Residency Program. Received 7 June 2005, received in final form 16 January 2006. Accepted 23 January 2006. D r. Joacir Graciolli Cord e i ro - Rua Alcides Munhoz 433 - Neuro c i ru rgia - 80810-040 Curitiba PR - Brasil. E-mail: joacirg c @ h o t m a i l . c o m CEREBRAL META S TASIS OF CERVICAL UTERINE CANCER Report of three cases Joacir Graciolli Cordeiro 1 , Daniel Monte-Serrat Prevedello 2 , Léo Fernando da Silva Ditzel 2 , Carlos Umberto Pereira 3 , João Cândido Araújo ...

Approximately 34,000 American women are diagnosed with uterine cancer each year. In most instances, the cause is unknown, but for one in 10 women with uterine cancer , an inherited predisposition may be involved. Genetic risk assessment for uterine cancer should be considered if a woman: s Has been diagnosed with uterine cancer at an early age (younger than 50) s Has been diagnosed with uterine cancer and another cancer , such as colon, ovarian, stomach or bile duct s Has a history of colon polyps before age 40 s Has family members with any of the above Of hereditary uterine cancers, approximately 50 to 70 percent are associated with the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, also known as Lynch syndrome. HNPCC is caused by the inheritance of a predisposing mutation ...

Trends in Cancer Mortality in Queensland Uterine cancer Rate per 100,000 population Mortality of Uterine cancer , among Females, Queensland, 1982 to 2002 Female 0 3 6 9 12 15 Year 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 Note: Rates are age standardised to the Australian population as at 30 June 2001. Data are reported by year of diagnosis. Uterine cancer is defined by the ICD-0-2 codes of C54 Source: Queensland Cancer Registry, Queensland Health and Queensland Cancer Fund. Generated by Epidemiology Services Unit, Queensland Health For more information: Health Status Indicators for Queensland Queensland Health Cancer Publications (http://www.health.qld.gov.au/hic/default.asp) Queensland Cancer Fund (http://www.qldcancer.com.au/) ...

Trends in Cancer Mortality in Queensland Uterine cancer Rate per 100,000 population Mortality of Uterine cancer, among Females, Queensland, 1982 to 2002 Female 0 3 6 9 12 15 Year 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 Note: Rates are age standardised to the Australian population as at 30 June 2001. Data are reported by year of diagnosis. Uterine cancer is defined by the ICD-0-2 codes of C54 Source: Queensland Cancer Registry, Queensland Health and Queensland Cancer Fund. Generated by Epidemiology Services Unit, Queensland Health For more information: Health Status Indicators for Queensland Queensland Health Cancer Publications (http://www.health.qld.gov.au/hic/default.asp) Queensland Cancer Fund (http://www.qldcancer.com.au/) ...

Cancer Incidence by Remoteness Category in Queensland Uterine cancer 0 5 10 15 20 25 30 Rate per 100,000 population Avg No. per Year Incidence of Uterine cancer among Females, by ARIA+ Category, Queensland, Five Year Average, 1998 to 2002 16.2 151 Major City ARIAplus Category 16.6 85 Inner Regional 14.5 41 Outer Regional 16.1 3 Remote 13.9 2 Very remote Note: Rates are age standardised to the Australian population as at 30 June 2001. Numbers and rates are averaged over five years, and based on place of usual residence at time of diagnosis. The range shown by the orange line corresponds to the 95% confidence interval for the estimated rate. Uterine cancer is defined by the ICD-0-2 codes of C54 . Source: ...